Gold-coated magnetic nanoparticle as a nanotheranostic agent for magnetic resonance imaging and photothermal therapy of cancer
- PMID: 28674789
- DOI: 10.1007/s10103-017-2267-x
Gold-coated magnetic nanoparticle as a nanotheranostic agent for magnetic resonance imaging and photothermal therapy of cancer
Abstract
Because of their great scientific and technological potentials, iron oxide nanoparticles (IONPs) have been the focus of extensive investigations in biomedicine over the past decade. Additionally, the surface plasmon resonance effect of gold nanoparticles (AuNPs) makes them a good candidate for photothermal therapy applications. The unique properties of both IONPs (magnetic) and AuNPs (surface plasmon resonance) may lead to the development of a multi-modal nanoplatform to be used as a magnetic resonance imaging (MRI) contrast agent and as a nanoheater for photothermal therapy. Herein, core-shell gold-coated IONPs (Au@IONPs) were synthesized and investigated as an MRI contrast agent and as a light-responsive agent for cancer photothermal therapy.The synthesized Au@IONPs were characterized by UV-visible spectroscopy, transmission electron microscopy (TEM), dynamic light scattering (DLS), and zeta potential analysis. The transverse relaxivity (r 2) of the Au@IONPs was measured using a 3-T clinical MRI scanner. Through a 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay, the cytotoxicity of the Au@IONs was examined on a KB cell line, derived from the epidermal carcinoma of a human mouth. Moreover, the photothermal effects of Au@IONPs in the presence of a laser beam (λ = 808 nm; 6.3 W/cm2; 5 min) were studied.The results show that the Au@IONPs are spherical with a hydrodynamic size of 33 nm. A transverse relaxivity of 95 mM-1 S-1 was measured for the synthesized Au@IONPs. It is evident from the MTT results that no significant cytotoxicity in KB cells occurs with Au@IONPs. Additionally, no significant cell damage induced by the laser is observed. Following the photothermal treatment using Au@IONPs, approximately 70% cell death is achieved. It is found that cell lethality depended strongly on incubation period and the Au@IONP concentration.The data highlight the potential of Au@IONPs as a dual-function MRI contrast agent and photosensitizer for cancer photothermal therapy.
Keywords: Cancer; Core–shell nanoparticles; Gold nanoparticles; MRI contrast agent; Magnetic nanoparticles; Photothermal therapy.
Similar articles
-
Polymer coated gold-ferric oxide superparamagnetic nanoparticles for theranostic applications.J Nanobiotechnology. 2018 Oct 13;16(1):80. doi: 10.1186/s12951-018-0405-7. J Nanobiotechnology. 2018. PMID: 30316298 Free PMC article.
-
Theranostic MUC-1 aptamer targeted gold coated superparamagnetic iron oxide nanoparticles for magnetic resonance imaging and photothermal therapy of colon cancer.Colloids Surf B Biointerfaces. 2016 Jul 1;143:224-232. doi: 10.1016/j.colsurfb.2016.02.058. Epub 2016 Feb 27. Colloids Surf B Biointerfaces. 2016. PMID: 27015647
-
Folic acid conjugated PEG coated gold-iron oxide core-shell nanocomplex as a potential agent for targeted photothermal therapy of cancer.Artif Cells Nanomed Biotechnol. 2018 Dec;46(8):1594-1604. doi: 10.1080/21691401.2017.1384384. Epub 2017 Oct 10. Artif Cells Nanomed Biotechnol. 2018. PMID: 28994325
-
Theranostics Based on Iron Oxide and Gold Nanoparticles for Imaging- Guided Photothermal and Photodynamic Therapy of Cancer.Curr Top Med Chem. 2017;17(16):1858-1871. doi: 10.2174/1568026617666161122120537. Curr Top Med Chem. 2017. PMID: 27875977 Review.
-
Polymer decorated gold nanoparticles in nanomedicine conjugates.Adv Colloid Interface Sci. 2017 Nov;249:386-399. doi: 10.1016/j.cis.2017.01.007. Epub 2017 Feb 15. Adv Colloid Interface Sci. 2017. PMID: 28259207 Review.
Cited by
-
Biomedical Applications of Iron Oxide Nanoparticles: Current Insights Progress and Perspectives.Pharmaceutics. 2022 Jan 16;14(1):204. doi: 10.3390/pharmaceutics14010204. Pharmaceutics. 2022. PMID: 35057099 Free PMC article. Review.
-
Smart and Multi-Functional Magnetic Nanoparticles for Cancer Treatment Applications: Clinical Challenges and Future Prospects.Nanomaterials (Basel). 2022 Oct 12;12(20):3567. doi: 10.3390/nano12203567. Nanomaterials (Basel). 2022. PMID: 36296756 Free PMC article. Review.
-
Iron Metabolism in Cancer.Int J Mol Sci. 2018 Dec 27;20(1):95. doi: 10.3390/ijms20010095. Int J Mol Sci. 2018. PMID: 30591630 Free PMC article. Review.
-
The Combination of Photothermal Therapy and Chemotherapy using Alginate-Modified Iron Oxide-Gold Nanohybrids Carrying Cisplatin.J Biomed Phys Eng. 2023 Apr 1;13(2):117-124. doi: 10.31661/jbpe.v0i0.2003-1083. eCollection 2023 Apr. J Biomed Phys Eng. 2023. PMID: 37082548 Free PMC article.
-
Multifunctional Mesoporous Polydopamine With Hydrophobic Paclitaxel For Photoacoustic Imaging-Guided Chemo-Photothermal Synergistic Therapy.Int J Nanomedicine. 2019 Nov 4;14:8647-8663. doi: 10.2147/IJN.S218632. eCollection 2019. Int J Nanomedicine. 2019. PMID: 31806962 Free PMC article.
References
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous